Follicular Helper CD4 T Cells (TFH)
S Crotty - Annual review of immunology, 2011 - annualreviews.org
T cell help to B cells is a fundamental aspect of adaptive immunity and the generation of
immunological memory. Follicular helper CD4 T (TFH) cells are the specialized providers of …
immunological memory. Follicular helper CD4 T (TFH) cells are the specialized providers of …
The hyper IgM syndromes
N Qamar, RL Fuleihan - Clinical reviews in allergy & immunology, 2014 - Springer
The hyper IgM syndromes are a group of rare inherited immune deficiency disorders
characterized by impairment of immunoglobulin isotype switching resulting from defects in …
characterized by impairment of immunoglobulin isotype switching resulting from defects in …
[HTML][HTML] Anti–interleukin-12 antibody for active Crohn's disease
PJ Mannon, IJ Fuss, L Mayer, CO Elson… - … England Journal of …, 2004 - Mass Medical Soc
Background Crohn's disease is associated with excess cytokine activity mediated by type 1
helper T (Th1) cells. Interleukin-12 is a key cytokine that initiates Th1-mediated inflammatory …
helper T (Th1) cells. Interleukin-12 is a key cytokine that initiates Th1-mediated inflammatory …
The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients
JA Winkelstein, MC Marino, H Ochs, R Fuleihan… - Medicine, 2003 - journals.lww.com
The X-linked hyper-IgM (XHIGM) syndrome is an uncommon primary immunodeficiency
disease caused by mutations in the gene for CD40 ligand and characterized by normal or …
disease caused by mutations in the gene for CD40 ligand and characterized by normal or …
Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia
The gene that encodes nuclear factor κ (NF-κB) essential modulator (or NEMO, also known
as IKKγ) is required for activation of the transcription factor NF-κB. We describe mutations in …
as IKKγ) is required for activation of the transcription factor NF-κB. We describe mutations in …
Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantation
MT de la Morena, D Leonard, TR Torgerson… - Journal of Allergy and …, 2017 - Elsevier
Background X-linked hyper-IgM syndrome (XHIGM) is a primary immunodeficiency with high
morbidity and mortality compared with those seen in healthy subjects. Hematopoietic cell …
morbidity and mortality compared with those seen in healthy subjects. Hematopoietic cell …
Persistent and selective deficiency of CD4+ T cell immunity to cytomegalovirus in immunocompetent young children
Healthy young children who acquire CMV have prolonged viral shedding into the urine and
saliva, but whether this is attributable to limitations in viral-specific immune responses has …
saliva, but whether this is attributable to limitations in viral-specific immune responses has …
Modeling, optimization, and comparable efficacy of T cell and hematopoietic stem cell gene editing for treating hyper‐IgM syndrome
V Vavassori, E Mercuri, GE Marcovecchio… - EMBO Molecular …, 2021 - embopress.org
Precise correction of the CD40LG gene in T cells and hematopoietic stem/progenitor cells
(HSPC) holds promise for treating X‐linked hyper‐IgM Syndrome (HIGM1), but its actual …
(HSPC) holds promise for treating X‐linked hyper‐IgM Syndrome (HIGM1), but its actual …
The role of novel T cell costimulatory pathways in autoimmunity and transplantation
A Yamada, AD Salama, MH Sayegh - Journal of the American …, 2002 - journals.lww.com
The CD28-B7 and CD154-CD40 pathways have been described as the critical costimulatory
pathways for T cell activation. Blockade of these pathways has been reported to regulate …
pathways for T cell activation. Blockade of these pathways has been reported to regulate …
Hyper IgM syndrome: a report from the USIDNET registry
EA Leven, P Maffucci, HD Ochs, PR Scholl… - Journal of clinical …, 2016 - Springer
Abstract Purpose The United States Immunodeficiency Network (USIDNET) patient registry
was used to characterize the presentation, genetics, phenotypes, and treatment of patients …
was used to characterize the presentation, genetics, phenotypes, and treatment of patients …